Treatment of Multiple Sclerosis With Intravenous Immunoglobulins-Reply

Anat Achiron; Elon Pras; Ronit Gilad; Ilan Ziv; Mathilda Mandel; Carlos R. Gordon; Shlomo Noy; Ida Sarova-Pinhas; Eldad Melamed

doi:10.1001/archneur.1994.00540150020007

Article

March 1994

Treatment of Multiple Sclerosis With Intravenous Immunoglobulins-Reply

Anat Achiron, MD, PhD; Elon Pras, MD; Ronit Gilad, MD; et al Ilan Ziv, MD; Mathilda Mandel, MD; Carlos R. Gordon, MD, PhD; Shlomo Noy, MD; Ida Sarova-Pinhas, MD; Eldad Melamed, MD

Author Affiliations

Petah Tiqwa, Israel

Arch Neurol. 1994;51(3):234. doi:10.1001/archneur.1994.00540150020007

Full Text

Abstract

In reply The article by Schuller and Govaerts,¹ has major differences compared with our study² regarding the patients treated, mode of treatment, dosage of drug used, and duration of treatment.Schuller and Govaerts¹ have treated patients with chronic progressive multiple sclerosis (MS), and their main results are related to the disability of the patients. We have treated pa

Full Text

Treatment of Multiple Sclerosis With Intravenous Immunoglobulins-Reply

Others Also Liked

Featured Articles

USPSTF Recommendation Statements

Blogs

Treatment of Multiple Sclerosis With Intravenous Immunoglobulins-Reply

Citation

Download citation file:

Others Also Liked

Select Your Interests